Report cover image

Europe Pharmacogenetic Testing Market - Industry Trends and Forecast to 2032

Publisher Data Bridge Market Research
Published Oct 01, 2023
Length 211 Pages
SKU # DAABD18360505

Description

Europe Pharmacogenetic Testing Market - Industry Trends and Forecast to 2032


The Europe pharmacogenetic testing market is expected to reach USD 3,423.04 million by 2030 from USD 1,864.88 million in 2022, growing at a CAGR of 8.1% during the forecast period of 2023 to 2030.

Market Segmentation
Europe Pharmacogenetic Testing Market, By Type (Whole Genome Sequencing, Whole Exome Sequencing, Array-Based Tests, and Single Gene Tests), Gene Type (CYP2C19, CYP2D6, CYP2C9 AND VKORC1, CYP1A2, HLA-B*1502, HLA-B*5701, CYP2D, OPRM1, ONCOTYPE DX AND MAMMAPRINT, DRD3, D4D4, SLC6A4, HTR2A/C, TMPT, and Others), Drug Type (Prescription Drugs, Nutraceuticals, Recreational Drugs, Herbal Supplements, Vitamins, and Over-the-Counter Medications), Sample (Blood and Saliva), Therapeutic Area (Cardiology, Gastroenterology, Anesthesiology, Genomics, Endocrinology, Immunology & Hypersensitivity, Dermatology, Gynecology, Oncology, Neurology, and Others), Application (Clinical Practice, Drug Development, and Drug Regulation), End User (Healthcare Providers, Pharmaceutical & Biotechnology Companies, Research Centres and Academic Institutes, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacies, Mail-Order Pharmacies, and Direct-to-Customer Services), Country (Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, and rest of Europe) - Industry Trends and Forecast to 2030

Overview of Global Pharmacogenetic Testing Market Dynamics

Driver
• Rapid technological advancement and miniaturization
Restrain

• Environment and health concerns
Opportunity

• Rising research and development and innovative technologies

Market Players

Some of the major market players operating in the Europe pharmacogenetic testing market are:

• Thermo Fisher Scientific
• Illumina, Inc
• QIAGEN
• Sonic Healthcare
• BGI

Table of Contents

211 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of Europe Pharmacogenetic Testing Market
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Dbmr Tripod Data Validation Model
2.5 Primary Interviews With Key Opinion Leaders
2.6 Dbmr Market Position Grid
2.7 Multivariate Modelling
2.8 Type Lifeline Curve
2.9 Market End User Coverage Grid
2.10 Secondary Sources
2.11 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestel Analysis
4.2 Porter’sfive Forces
4.3 Industry Insights And Strategic Analysis
5 Market Overview
5.1 Drivers
5.1.1 Increasing Adoption Of Personalized Medicine
5.1.2 Advancements In Genomic Technologies
5.1.3 Increasing Chronic And Complex Diseases
5.1.4 Role Of Pharmacogenetic Testing In Drug Discovery And Development
5.2 Restraints
5.2.1 Dependency On The Medical And Genomic Expert For Result Interpretation
5.2.2 Ethical And Privacy Concerns Associated With Pharmacogenetic Testing
5.3 Opportunities
5.3.1 Integration With Electronic Health Records (Ehrs)
5.3.2 Artificial Intelligence (Ai) And Machine Learning Integration In Healthcare
5.4 Challenges
5.4.1 Challenges In Clinical Implementation Of Pharmacogenetics
5.4.2 Complexity Associated With Pharmacogenetic Testing Results
6 Europe Pharmacogenetic Testing Market, By Type
6.1 Overview
6.2 Whole Genome Sequencing
6.2.1 Next Generation Sequencing (Ngs)
6.2.2 Sanger Sequencing
6.3 Whole Exome Sequencing
6.3.1 Next Generation Sequencing (Ngs)
6.3.2 Sanger Sequencing
6.4 Array-based Tests
6.4.1 Glass Slide Arrays
6.4.2 In—situ Synthesized Arrays
6.4.3 Self Assembled Arrays
6.5 Single Gene Tests
6.5.1 Next Generation Sequencing (Ngs)
6.5.2 Sanger Sequencing
7 Europe Pharmacogenetic Testing Market, By Gene Type
7.1 Overview
7.2 Cyp2c19
7.3 Cyp2d6
7.4 Cyp2c9 And Vkorc1
7.5 Cyp1a2
7.6 Hla-b*1502
7.7 Hla-b*5701
7.8 Cyp2d
7.9 Oprm1
7.10 Oncotype Dx* And Mammaprint
7.11 Drd3
7.12 D4d4
7.13 Slc6a4
7.14 Htr2a/C
7.15 Tmpt
7.16 Others
8 Europe Pharmacogenetic Testing Market, By Drug Type
8.1 Overview
8.2 Prescription Drugs
8.3 Nutraceuticals
8.4 Recreational Drugs
8.5 Herbal Supplements
8.6 Vitamins
8.7 Over-the-counter Medications
9 Europe Pharmacogenetic Testing Market, By Sample
9.1 Overview
9.2 Blood
9.3 Saliva
10 Europe Pharmacogenetic Testing Market, By Therapeutic Area
10.1 Overview
10.2 Cardiology
10.3 Gastroenterology
10.4 Anesthesiology
10.5 Genomics
10.6 Endocrinology
10.7 Immunology & Hypersensitivity
10.8 Dermatology
10.9 Gynecology
10.10 Oncology
10.11 Neurology
10.12 Others
11 Europe Pharmacogenetic Testing Market, By Application
11.1 Overview
11.2 Clinical Practice
11.2.1 Side Effects
11.2.2 Drug Effectiveness
11.2.3 Dosage
11.3 Drug Development
11.3.1 Drug Effectiveness
11.3.2 Dosage
11.3.3 Side Effects
11.4 Drug Regulation
11.4.1 Side Effects
11.4.2 Drug Effectiveness
11.4.3 Dosage
12 Europe Pharmacogenetic Testing Market, By End User
12.1 Overview
12.2 Healthcare Providers
12.3 Pharmaceutical & Biotechnology Companies
12.4 Research Centres And Academic Institutes
12.5 Others
13 Europe Pharmacogenetic Testing Market, By Distribution Channel
13.1 Overview
13.2 Hospital Pharmacy
13.3 Retail Pharmacies
13.4 Mail-order Pharmacies
13.5 Direct-to-customer Services
14 Europe Pharmacogenetic Testing Market, By Region
14.1 Europe
15 Europe Pharmacogenetic Testing Market: Company Landscape
15.1 Company Share Analysis: Europe
16 Swot Analysis
17 Company Profile
17.1 Thermo Fisher Scientific Inc.
17.1.1 Company Snapshot
17.1.2 Revenue Analysis
17.1.3 Company Share Analysis
17.1.4 Product Portfolio
17.1.5 Recent Developments
17.2 Illumina, Inc.
17.2.1 Company Snapshot
17.2.2 Revenue Analysis
17.2.3 Company Share Analysis
17.2.4 Product Portfolio
17.2.5 Recent Development
17.3 Qiagen
17.3.1 Company Snapshot
17.3.2 Revenue Analysis
17.3.3 Company Share Analysis
17.3.4 Product Portfolio
17.3.5 Recent Development
17.4 Sonic Healthcare
17.4.1 Company Snapshot
17.4.2 Revenue Analysis
17.4.3 Company Share Analysis
17.4.4 Product Portfolio
17.4.5 Recent Development
17.5 Bgi
17.5.1 Company Snapshot
17.5.2 Company Share Analysis
17.5.3 Product Portfolio
17.5.4 Recent Development
17.6 23andme, Inc
17.6.1 Company Snapshot
17.6.2 Revenue Analysis
17.6.3 Product Portfolio
17.6.4 Recent Development
17.7 Dynamic Dna Laboratories
17.7.1 Company Snapshot
17.7.2 Product Portfolio
17.7.3 Recent Development
17.8 Eurofins Scientific (2022)
17.8.1 Company Snapshot
17.8.2 Revenue Analysis
17.8.3 Product Portfolio
17.8.4 Recent Development
17.9 Genewix (A Subsidiary Of Azenta Life Science)
17.9.1 Company Snapshot
17.9.2 Product Portfolio
17.9.3 Recent Development
17.10 Luminex Corporation (A Subsidiary Of Diasorin)
17.10.1 Company Snapshot
17.10.2 Product Portfolio
17.10.3 Recent Development
17.11 Md Labs
17.11.1 Company Snapshot
17.11.2 Product Portfolio
17.11.3 Recent Development
17.12 Myriad Genetics, Inc.
17.12.1 Company Snapshot
17.12.2 Revenue Analysis
17.12.3 Product Portfolio
17.12.4 Recent Developments
17.13 Oneome
17.13.1 Company Snapshot
17.13.2 Product Portfolio
17.13.3 Recent Development
17.14 Pacbio
17.14.1 Company Snapshot
17.14.2 Revenue Analysis
17.14.3 Product Portfolio
17.14.4 Recent Development
17.15 Perkinelmer Inc.
17.15.1 Company Snapshot
17.15.2 Revenue Analysis
17.15.3 Product Portfolio
17.15.4 Recent Development
17.16 Pgxt
17.16.1 Company Snapshot
17.16.2 Product Portfolio
17.16.3 Recent Development
18 Questionnaire
19 Related Reports
List Of Tables
Table 1 Europe Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 2 Europe Whole Genome Sequencing In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 3 Europe Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 4 Europe Whole Exome Sequencing In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 5 Europe Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 6 Europe Array-based Tests In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 7 Europe Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 8 Europe Single Gene Tests In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 9 Europe Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 10 Europe Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million)
Table 11 Europe Cyp2c19 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 12 Europe Cyp2d6 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 13 Europe Cyp2c9 And Vkorc1 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 14 Europe Cyp1a2 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 15 Europe Hla-b*1502 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 16 Europe Hla-b*5701 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 17 Europe Cyp2d In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 18 Europe Oprm1 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 19 Europe Oncotype Dx* And Mammaprint In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 20 Europe Drd3 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 21 Europe D4d4 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 22 Europe Slc6a4 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 23 Europe Htr2a/C In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 24 Europe Tmpt In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 25 Europe Others In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 26 Europe Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million)
Table 27 Europe Prescription Drugs In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 28 Europe Nutraceuticals In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 29 Europe Recreational Drugs In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 30 Europe Herbal Supplements In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 31 Europe Vitamins In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 32 Europe Over-the-counter Medications In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 33 Europe Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million)
Table 34 Europe Blood In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 35 Europe Saliva In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 36 Europe Pharmacogenetic Testing Market, By Therpaeutic Area, 2021-2030 (Usd Million)
Table 37 Europe Cardiology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 38 Europe Gastroenterology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 39 Europe Anesthesiology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 40 Europe Genomics In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 41 Europe Endocrinology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 42 Europe Immunology & Hypersensitivity In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 43 Europe Dermatology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 44 Europe Gynecology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 45 Europe Oncology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 46 Europe Neurology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 47 Europe Others In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 48 Europe Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 49 Europe Clinical Practice In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 50 Europe Clinical Practice In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 51 Europe Drug Development In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 52 Europe Drug Development In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 53 Europe Drug Regulation In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 54 Europe Drug Regulation In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 55 Europe Pharmacogenetic Testing Market, By End User, 2021-2030 (Usd Million)
Table 56 Europe Healthcare Providers In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 57 Europe Pharmaceutical & Biotechnology Companies In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 58 Europe Research Centres And Academic Institutes In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 59 Europe Others In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 60 Europe Pharmacogenetic Testing Market, By Distribution Channel, 2020-2030 (Usd Million)
Table 61 Europe Hospital Pharmacy In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 62 Europe Retail Pharmacies In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 63 Europe Mail-order Pharmacies In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 64 Europe Direct-to-customer Services In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million)
Table 65 Europe Pharmacogenetic Testing Market, By Country, 2021-2030 (Usd Million)
Table 66 Europe Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 67 Europe Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 68 Europe Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 69 Europe Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 70 Europe Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 71 Europe Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million)
Table 72 Europe Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million)
Table 73 Europe Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million)
Table 74 Europe Pharmacogenetic Testing Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 75 Europe Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 76 Europe Clinical Practice In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 77 Europe Drug Development In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 78 Europe Drug Regulation In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 79 Europe Pharmacogenetic Testing Market, By End User, 2021-2030 (Usd Million)
Table 80 Europe Pharmacogenetic Testing Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 81 Germany Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 82 Germany Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 83 Germany Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 84 Germany Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 85 Germany Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 86 Germany Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million)
Table 87 Germany Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million)
Table 88 Germany Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million)
Table 89 Germany Pharmacogenetic Testing Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 90 Germany Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 91 Germany Clinical Practice In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 92 Germany Drug Development In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 93 Germany Drug Regulation In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 94 Germany Pharmacogenetic Testing Market, By End User, 2021-2030 (Usd Million)
Table 95 Germany Pharmacogenetic Testing Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 96 France Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 97 France Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 98 France Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 99 France Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 100 France Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 101 France Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million)
Table 102 France Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million)
Table 103 France Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million)
Table 104 France Pharmacogenetic Testing Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 105 France Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 106 France Clinical Practice In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 107 France Drug Development In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 108 France Drug Regulation In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 109 France Pharmacogenetic Testing Market, By End User, 2021-2030 (Usd Million)
Table 110 France Pharmacogenetic Testing Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 111 U.K. Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 112 U.K. Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 113 U.K. Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 114 U.K. Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 115 U.K. Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 116 U.K. Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million)
Table 117 U.K. Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million)
Table 118 U.K. Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million)
Table 119 U.K. Pharmacogenetic Testing Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 120 U.K. Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 121 U.K. Clinical Practice In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 122 U.K. Drug Development In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 123 U.K. Drug Regulation In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 124 U.K. Pharmacogenetic Testing Market, By End User, 2021-2030 (Usd Million)
Table 125 U.K. Pharmacogenetic Testing Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 126 Italy Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 127 Italy Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 128 Italy Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 129 Italy Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 130 Italy Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 131 Italy Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million)
Table 132 Italy Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million)
Table 133 Italy Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million)
Table 134 Italy Pharmacogenetic Testing Market, By Therapeutic Area, 2021-2030 (Usd Million)
Table 135 Italy Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 136 Italy Clinical Practice In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 137 Italy Drug Development In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 138 Italy Drug Regulation In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million)
Table 139 Italy Pharmacogenetic Testing Market, By End User, 2021-2030 (Usd Million)
Table 140 Italy Pharmacogenetic Testing Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 141 Spain Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 142 Spain Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 143 Spain Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 144 Spain Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 145 Spain Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million)
Table 146 Spain Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million)
Table 147 Spain Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million)
Table 148 Spain Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million)
Table 149 Spain Pharmacogenetic Testing Market, By Therapeutic Area, 2021-2030 (Usd Million)
List Of Figures
Figure 1 Europe Pharmacogenetic Testing Market: Segmentation
Figure 2 Europe Pharmacogenetic Testing Market: Data Triangulation
Figure 3 Europe Pharmacogenetic Testing Market: Droc Analysis
Figure 4 Europe Pharmacogenetic Testing Market: Europe Vs Regional Market Analysis
Figure 5 Europe Pharmacogenetic Testing Market: Company Research Analysis
Figure 6 Europe Pharmacogenetic Testing Market: Interview Demographics
Figure 7 Europe Pharmacogenetic Testing Market: Dbmr Market Position Grid
Figure 8 Europe Pharmacogenetic Testing Market: Market End User Coverage Grid
Figure 9 Europe Pharmacogenetic Testing Market: Segmentation
Figure 10 Increasing Adoption Of Personalized Medicine Is Driving The Growth Of The Europe Pharmacogenetic Testing Market In The Forecast Period Of 2023 To 2030
Figure 11 Whole Genome Sequencing Segment Is Expected To Account For The Largest Share Of The Europe Pharmacogenetic Testing Market In 2023 & 2030
Figure 12 Drivers, Restraints, Opportunities, And Challenges Of Europe Pharmacogenetic Testing Market
Figure 13 Europe Pharmacogenetic Testing Market: By Type, 2022
Figure 14 Europe Pharmacogenetic Testing Market: By Type, 2023-2030 (Usd Million)
Figure 15 Europe Pharmacogenetic Testing Market: By Type, Cagr (2023-2030)
Figure 16 Europe Pharmacogenetic Testing Market: By Type, Lifeline Curve
Figure 17 Europe Pharmacogenetic Testing Market: By Gene Type, 2022
Figure 18 Europe Pharmacogenetic Testing Market: By Gene Type, 2023-2030 (Usd Million)
Figure 19 Europe Pharmacogenetic Testing Market: By Gene Type, Cagr (2023-2030)
Figure 20 Europe Pharmacogenetic Testing Market: By Gene Type, Lifeline Curve
Figure 21 Europe Pharmacogenetic Testing Market: By Drug Type, 2022
Figure 22 Europe Pharmacogenetic Testing Market: By Drug Type, 2023-2030 (Usd Million)
Figure 23 Europe Pharmacogenetic Testing Market: By Drug Type, Cagr (2023-2030)
Figure 24 Europe Pharmacogenetic Testing Market: By Drug Type, Lifeline Curve
Figure 25 Europe Pharmacogenetic Testing Market: By Sample, 2022
Figure 26 Europe Pharmacogenetic Testing Market: By Sample, 2023-2030 (Usd Million)
Figure 27 Europe Pharmacogenetic Testing Market: By Sample, Cagr (2023-2030)
Figure 28 Europe Pharmacogenetic Testing Market: By Sample, Lifeline Curve
Figure 29 Europe Pharmacogenetic Testing Market: By Therapeutic Area, 2022
Figure 30 Europe Pharmacogenetic Testing Market: By Therapeutic Area, 2023-2030 (Usd Million)
Figure 31 Europe Pharmacogenetic Testing Market: By Therapeutic Area, Cagr (2023-2030)
Figure 32 Europe Pharmacogenetic Testing Market: By Therapeutic Area, Lifeline Curve
Figure 33 Europe Pharmacogenetic Testing Market: By Application, 2022
Figure 34 Europe Pharmacogenetic Testing Market: By Application, 2023-2030 (Usd Million)
Figure 35 Europe Pharma

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us